ELVN EBITDA Growth
Enliven Therapeutics Inc · EBITDA Growth
ELVN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-5.90%period ending
ELVN TTM EBITDA YoY % (-76.11% → -5.90%)
Year-over-year change
High-resolution chart · PNG
ELVN ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -5.9039% | |
| -4.5479% | |
| -16.9042% | |
| -14.4602% | |
| -21.4117% | |
| -18.9144% | |
| -24.111% | |
| -37.7125% | |
| -60.4438% | |
| -82.3826% | |
| -90.3677% | |
| -69.2759% | |
| -30.0008% | |
| 0.6263% | |
| 17.4267% | |
| 25.0918% | |
| 16.5295% | |
| 1.255% | |
| -9.9048% | |
| -31.068% | |
| -51.4339% | |
| -67.6467% | |
| -76.1118% |